{"id":"W2947177174","doi":"10.1016/j.dsx.2019.05.034","title":"Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?","year":2019,"lang":"en","type":"review","venue":"Diabetes & Metabolic Syndrome Clinical Research & Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"MSD K.K.; Daiichi Sankyo Company; Shionogi; National Institute of Biomedical Innovation; Astellas Pharma; Mochida Pharmaceutical Company; Teijin Pharma; Novo Nordisk; Daiichi-Sankyo; Boehringer Ingelheim Japan; XBiotech; Kowa Pharmaceutical Europe; Takeda Pharmaceuticals U.S.A.; Takeda Pharmaceuticals North America; IFM Therapeutics; Novartis Pharma; Otsuka Pharmaceutical; Bayer Yakuhin; Novartis; AstraZeneca; Amgen; Pfizer; Astellas Pharma US; Kaken Pharmaceutical; Sanofi; Merck","keywords":"Residual; Key (lock); Residual risk; Diabetes mellitus; Alpha (finance); Risk analysis (engineering); Medicine; Computer science; Internal medicine; Endocrinology; Computer security; Surgery; Algorithm","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity"],"category_scores_codex":[0.1178363,0.001557537,0.01624829,0.0007246058,0.0006304577,0.0003201979,0.003552364,0.001470936,0.0005616616],"category_scores_gemma":[0.03570259,0.0007204306,0.009599023,0.004394202,0.002231555,0.0002740556,0.001566625,0.01175582,0.002449783],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002899762,"about_ca_system_score_gemma":0.002679204,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002546897,"about_ca_topic_score_gemma":0.00002884549,"domain_scores_codex":[0.9456764,0.03736107,0.006315103,0.002678455,0.004488731,0.003480243],"domain_scores_gemma":[0.9734609,0.01326317,0.001748783,0.009661812,0.0006644976,0.001200914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000009266834,0.0003505217,0.002582368,0.01558861,0.002400607,0.00005903775,0.0000711818,4.116785e-7,1.405251e-7,0.0001598196,0.006653018,0.972125],"study_design_scores_gemma":[0.001381314,0.0006158131,0.01087135,0.02645709,0.006316445,0.00003863684,0.00003305443,0.00001142567,8.19339e-7,0.0001318735,0.9534516,0.0006906193],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005849866,0.9712682,0.00000178426,0.0008539438,0.001094035,0.0203228,0.000147679,0.00007170677,0.0003899205],"genre_scores_gemma":[0.0002094757,0.9892813,0.000105322,0.001158647,0.002891636,0.004727082,0.0002556987,0.0003218926,0.001048968],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9714344,"threshold_uncertainty_score":0.9998254,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2015271280633693,"score_gpt":0.4693923407127744,"score_spread":0.2678652126494051,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}